Every year in September, the HIV Cure Research Center organized a lively HIV-oriented symposium in the picturesque city of Ghent, Belgium. Since the pandemic outbreak of SARS-CoV-2 in 2020, the lab has also invested heavily in the initiation of key research in COVID-19. Therefore, for the second year in a row, we decided to organize an HIV and SARS-CoV-2 hybrid symposium, which will take place the 21nd of October. During this symposium we will discuss key aspects of SARS-CoV-2 pathogenesis and HIV cure.
We walk you through the basic principles of SARS-CoV-2 pathogenesis, pathophysiology and SARS-CoV-2 protection by vaccination. In addition, we focus on HIV reservoirs and cure.
The HIV and SARS-CoV-2 hybrid symposium will comprehensively summarize the state of the art in COVID-19 and HIV cure strategies.
Please forward this invitation to colleagues within your network.
CALL FOR ABSTRACTS
The HIV Cure Research Center invites you to submit abstracts for oral presentations for the HIV and SARS-CoV-2 Hybrid Symposium to be held on Thursday, October 21, 2021 at the Roularta Center, Zellik, Belgium or online. The length of abstracts for presentations should not exceed 350 words. Ten minutes will be foreseen for each oral presentation.
The deadline for abstract submission is September 10, 2021. Notification of acceptance will be made on September 24, 2021. Please send abstracts as Pdf document to Karen Vervisch, email@example.com by September 10.
On behalf of the organizing committee of the HIV and SARS-CoV-2 symposium.
HIV Cure Research Center